A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 72
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : IBS-SSS
Long Form : IBS Symptom Severity Scale
No. Year Title Co-occurring Abbreviation
2021 A carbohydrate-restricted diet for patients with irritable bowel syndrome lowers serum C-peptide, insulin, and leptin without any correlation with symptom reduction. CI, IBS, SSRD
2021 A pilot feasibility study of an unguided, internet-delivered cognitive behavioral therapy program for irritable bowel syndrome. CBT, GAD-7, IBS, PHQ-9
2021 A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome. BSFS, HADS, IBS-D, ITT
2021 Acupuncture for the treatment of diarrheal-predominant irritable bowel syndrome: study protocol for a pilot randomized controlled trial. IBS, IBS-AR, IBS-QOL, NA, NSA, PHQ-9, SA
2021 Better response to low FODMAP diet in disorders of gut-brain interaction patients with pronounced hydrogen response to a nutrient challenge test. CI, DGBI, IBS, LFD, NCT
2021 Differences in dietary habits of people with vs without irritable bowel syndrome and their association with symptom and psychological status: A pilot study. HADS, IBS
2021 Efficacy of acupuncture based on acupoint combination theory for irritable bowel syndrome: a study protocol for a multicenter randomized controlled trial. BSFS, IBS, IBS-QOL, SAS, SDS, WSAS
2021 Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms. ASVs, FMT, IBS
2021 Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome. F/B, FC, GFD, GI, IBS, LF-GFD
10  2021 Long-term safety and efficacy study of a medical device containing xyloglucan, pea protein reticulated with tannins and xylo-oligosaccharides, in patients with diarrhoea-predominant irritable bowel syndrome. IBS-D, PPT, XG, XOS
11  2021 Metabolic Profiling of Plasma in Patients with Irritable Bowel Syndrome after a 4-Week Starch- and Sucrose-Reduced Diet. GC-MS, IBS, LC-MS, SSRD, VAS-IBS
12  2021 No distinction in the gut microbiota between diarrhea predominant-irritable bowel syndrome and healthy subjects: matched case-control study in Thailand. IBS
13  2021 Regulation of serum microRNA expression by acupuncture in patients with diarrhea-predominant irritable bowel syndrome. IBS-D, miRNAs, qRT-PCR, TLDA
14  2021 The Role of Brain-Derived Neurotrophic Factor in Irritable Bowel Syndrome. BDNF, IBS
15  2021 [Bidirectional regulation of acupuncture: a subgroup analysis of multicenter randomized controlled trial of acupuncture with Tiaoshen Jianpi for irritable bowel syndrome]. IBS, IBS-D, IBS-QOL, PEG
16  2021 [Correlation between curative effect and 5-HTTLPR polymorphism in treatment of diarrhea-predominant irritable bowel syndrome with acupuncture for regulating shen and strengthening spleen]. 5-HTTLPR, IBS-D, IBS-QOL
17  2021 [Effect of Tiaoshen Jianpi acupuncture therapy on gut microbiota and fecal short-chain fatty acids in patients with diarrhea type irritable bowel syndrome]. IBS-D, SCFAs
18  2021 [Mind-regulating and spleen-strengthening needling technique improves abdominal hypersensitivity and emotion by enhancing functional connectivity between hippocampus and brain regions in diarrhea-predominant irritable bowel syndrome patients]. FC, HAM-A, IBS-D, rs-fMRI
19  2021 [Tiaoshen acupuncture method combined with electroacupuncture for diarrhea-type irritable bowel syndrome : a randomized controlled trial]. EA, HAMD, IBS-D, IBS-QOL
20  2020 Anti-irritable Bowel Syndrome Syrup Improves Constipation-Predominant Irritable Bowel Syndrome: A Randomized, Placebo-Controlled Trial. BSFS, HADS
21  2020 Characterization of kynurenine pathway in patients with diarrhea-predominant irritable bowel syndrome. IBS-D, KYN, KYNA, NMDAR2B, QUIN, SAS, SDS, Trp
22  2020 Efficacy and Safety of a Novel Herbal Medicine in the Treatment of Irritable Bowel Syndrome: A Randomized Double-Blinded Clinical Trial. IBS, IBS-AR, IBS-GAI, ZM
23  2020 Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial. AR, IBS, IBS-D, IBS-QOL, TCM
24  2020 Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial. APS-NRS, IBS
25  2020 Randomized clinical trial: Effects of Aloe barbadensis Mill. extract on symptoms, fecal microbiota and fecal metabolite profiles in patients with irritable bowel syndrome. IBS
26  2020 Study on the clinical mechanism of Tong-Xie-An-Chang Decoction in the treatment of diarrheal irritable bowel syndrome based on single-cell sequencing technology. IBS-D, IBS-QOL, TCM, TXACD
27  2020 The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome-A Randomized Double-Blind, Placebo-Controlled Study. IBS-GIS
28  2020 [Therapeutic effect of herb-separated moxibustion at Jinsuo (GV 8)-eight-diagram points on diarrhea-type irritable bowel syndrome of liver stagnation and spleen deficiency]. GI, IBS-D, IBS-QOL, TCM
29  2019 A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain. HS, IBS-C, QoL
30  2019 Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome. BSFS, HCs, IBS, IBS-D, IBS-D
31  2019 Assessing telephone-delivered cognitive-behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial. CBT, TAU, TCBT, WCBT, WSAS
32  2019 Breath Methane Does Not Correlate With Constipation Severity or Bloating in Patients With Constipation. GBT, IBS, PAC-SYM
33  2019 Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive and extra-digestive symptoms. IBS
34  2019 Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial. ACTIB, CBT, IBS, ITT, WSAS
35  2019 Effect of cognitive behavior therapy combined with exercise intervention on the cognitive bias and coping styles of diarrhea-predominant irritable bowel syndrome patients. ATQ, CSQ, DAS, IBS, IBS-D
36  2019 Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial. FMT, IBS
37  2019 Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management? FODMAPs, IBS
38  2018 Acupuncture for irritable bowel syndrome: study protocol for a multicenter randomized controlled trial. IBS, IBS-QoL, PCR-RFLP, WGO
39  2018 Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up. CBT, EDU
40  2018 Effect of acupuncture and its influence on visceral hypersensitivity in IBS-D patients: Study protocol for a randomized controlled trial. IBS
41  2018 Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial. AR, CM, HADS, IBS, IBS-QOL, TCKM
42  2018 Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome. FODMAPs, IBS, RI
43  2018 Lacto-fermented sauerkraut improves symptoms in IBS patients independent of product pasteurisation - a pilot study. IBS, LAB, PS, UPS
44  2018 UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation. IBS-C
45  2018 [Clinical effect of abdominal acupuncture for diarrhea irritable bowel syndrome]. IBS-D
46  2017 Evaluation of Benefit and Tolerability of IQP-CL-101 (Xanthofen) in the Symptomatic Improvement of Irritable Bowel Syndrome: A Double-Blinded, Randomised, Placebo-Controlled Clinical Trial. IBS
47  2017 Functional Bowel Disorders Are Associated with a Central Immune Activation. CSF, FGID, IBS, IL, PC, SCFA
48  2017 Irritable bowel syndrome symptom severity improves equally with probiotic and placebo. IBS, QoL
49  2017 Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies. FODMAP, IBS, SD
50  2017 Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. IBD, IBS, IQR, LFD, ND, Rome III, SIBDQ
51  2017 Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs. DI, FODMAPs
52  2017 [Acupuncture with regulating mind and spleen for diarrhea irritable bowel syndrome and sleep quality:a randomized controlled trial]. IBS-D, PSQI
53  2017 [Visceral sensitivity, gut barrier function and autonomic nerve function in patients with diarrhea-predominant irritable bowel syndrome]. ANF, DAO, HAMA, HAMD, IBS-D, VSI
54  2016 Co-Administration of Soy Isoflavones and Vitamin D in Management of Irritable Bowel Disease. IBS
55  2016 Feasibility and Usability Pilot Study of a Novel Irritable Bowel Syndrome Food and Gastrointestinal Symptom Journal Smartphone App. GI, IBS, SUS
56  2016 FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. FODMAP, LBT
57  2016 Long-term response to gluten-free diet as evidence for non-celiac wheat sensitivity in one third of patients with diarrhea-dominant and mixed-type irritable bowel syndrome. EQ-5D, GFD, IBS, IBS-QoL
58  2016 Therapeutic Effect of Chang'an I Recipe ( I ) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial. AR, CI, CM, FAS, HAD, IBS-D, IBS-QOL, PPS
59  2016 [Analysis of Response of IBS-SSS, AR, and IBS-QOL in IBS Clinical Effect Evaluation]. AR, CM, CR I, HADa, HADd, IBS, IBS-QOL
60  2015 Does oral alpha-galactosidase relieve irritable bowel symptoms? AG, GI, IBS, QoL
61  2014 Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study. IBS, IBS-QOL
62  2014 Traditional Chinese medicine (Shun-Qi-Tong-Xie Granule) for irritable bowel syndrome: study protocol for a randomised controlled trial. IBS, IBS-D, IBS-QOL, SQTX Granule, TCM
63  2013 An open-label trial of duloxetine in patients with irritable bowel syndrome and comorbid generalized anxiety disorder. CGI, GAD, IBS, IBS-QOL
64  2013 Multidomain patient-reported outcomes of irritable bowel syndrome: exploring person-centered perspectives to better understand symptom severity scores. IBS
65  2013 Negative aspects of close relationships are more strongly associated than supportive personal relationships with illness burden of irritable bowel syndrome. NI
66  2012 Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. COMT, IBS
67  2012 Efficacy of Solifenacin on Irritable Bowel Syndrome With Diarrhea: Open-label Prospective Pilot Trial. IBS-D
68  2011 Evaluation of latent links between irritable bowel syndrome and sleep quality. BMI, IBS, IRT, PSQI
69  2011 Linguistic validation of the Irritable Bowel Syndrome-Quality of Life Questionnaire for Iranian patients. HADS, IBS-QOL, ICC
70  2011 Placebos without deception: a randomized controlled trial in irritable bowel syndrome. IBS, IBS-AR, IBS-GIS, IBS-QoL
71  2009 A treatment trial of acupuncture in IBS patients. IBS, IBS-AR, IBS-GIS, IBS-QOL
72  2009 Adequate relief in a treatment trial with IBS patients: a prospective assessment. AR, IBS, IBS-GAI, IBS-QOL